Shares of MDXHealth SA (NASDAQ:MXDHF) have earned an average broker rating score of 2.00 (Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a buy rating.

Brokerages have set a twelve-month consensus price objective of $7.90 for the company, according to Zacks. Zacks has also assigned MDXHealth SA an industry rank of 119 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research upgraded MDXHealth SA from a “hold” rating to a “buy” rating and set a $6.25 target price for the company in a research note on Friday, September 15th.

COPYRIGHT VIOLATION NOTICE: This report was published by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/11/04/zacks-mdxhealth-sa-mxdhf-receives-consensus-rating-of-buy-from-analysts.html.

Shares of MDXHealth SA (NASDAQ MXDHF) opened at $5.34 on Friday.

Get a free copy of the Zacks research report on MDXHealth SA (MXDHF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for MDXHealth SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDXHealth SA and related companies with MarketBeat.com's FREE daily email newsletter.